IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY22 results · Jul–Sep 2021
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹537.88 crore (up 0.8% from Q2 FY21) and net profit of ₹30.84 crore (down 75.7% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 537.88 | 533.48 | +0.8% | 518.51 | +3.7% |
| Other income | 10.51 | 4.48 | +134.6% | 5.72 | +83.7% |
| Total income | 548.39 | 537.96 | +1.9% | 524.23 | +4.6% |
| Profit before tax | 41.62 | 165.05 | −74.8% | 89.85 | −53.7% |
| Net profit for the period | 30.84 | 126.96 | −75.7% | 67.00 | −54.0% |
| EPS, basic (₹) | 5.26 | 21.61 | −75.7% | 11.41 | −53.9% |
| Net margin (%) | 5.7 | 23.8 | 12.9 |
Standalone
- Filed with BSE
- 12 Nov 2021, 19:55 IST
- Board meeting
- 12 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Audited
- Source
- XBRL filing on BSE